aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
CardioFocus, founded in Marlborough, United States, is a biotechnology company dedicated to advancing ablation treatments for cardiac disorders. The company's core mission is to provide physicians with cutting-edge technologies to manage complex cardiac arrhythmias, particularly atrial fibrillation. CardioFocus offers innovative solutions that utilize advanced laser technology and customized pulsed field ablation (PFA) waveform design, aiming for precise and effective treatment. Their products are designed to shorten procedure times, enabling more efficient ablations while maintaining high standards of care.
Notable affiliated individuals and investors include experts and leaders in the field of cardiology and medical device innovation. CardioFocus has achieved significant milestones in the development and commercialization of its technologies, contributing to improved outcomes in cardiac care. The company's impact is evident in its ability to enhance the precision and efficiency of cardiac ablation procedures, ultimately benefiting both physicians and patients by advancing the treatment of atrial fibrillation.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Medical Devices
Technology
Biotech
Tags
Healthtech
Model Types
Hardware
Revenue Type(s)
Recurring
Customer Type(s)
Consumers, Enterprise
Geographic Exposure
United States
When was CardioFocus founded?
CardioFocus was founded in 1990.
Where is CardioFocus’s headquarters located?
CardioFocus’s headquarters is located in Marlborough, MA, US.
How many employees does CardioFocus have?
CardioFocus has 71 employees as of Feb 5, 2024.
How much has CardioFocus raised to-date?
As of July 05, 2023, CardioFocus has raised a total of $268M (USD) since Feb 23, 2023.
Add Comparison
Total Raised to Date
$268M
USD
Last Update Feb 23, 2023
Total Employees Over Time
71
As of Feb 2024
CardioFocus Address
500 Nickerson Road
Suite 500-200
Marlborough,
Massachusetts
01752-4695
United States of America
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts